The Impact of Eicosapentaenoic Acid Pretreatment on Periprocedural Microcirculatory Damage in Patients Undergoing Percutaneous Coronary Interventio
Not Applicable
- Conditions
- Patients with stable angina pectoris who undergo percutaneous coronary intervention
- Registration Number
- JPRN-UMIN000002886
- Lead Sponsor
- Cardiovascular Division, Hyogo College of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1)Target PCI lesion is left main coronary artery 2)Target PCI lesion is graft stenosis or in-stent restenosis 3)Patients on hemodialysis 4)Patients with acute coronary syndrome 5)Patients with contraindication of antiplatelet of anticoagulation drug 6)Patients with a history of hypersensitivity to any of the components of the product 7)Patients who are judged by the principal investigator to be ineligible for enrollment in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in index of microcirculatory index
- Secondary Outcome Measures
Name Time Method 1)Absolute value of the CK-MB and high-sensitive troponin I measured at 8 and 24 hours after PCI 2)Absolute and percent changes of lipid profiles 3)Absolute and percent changes of high-sensitive CRP, VCAM-1, and MMP-9